- Home
- STEM vs EPRX Comparison
STEM vs EPRX Comparison
Compare STEM & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEM
- EPRX
- Stock Information
- Founded
- STEM 2009
- EPRX 2011
- Country
- STEM United States
- EPRX Canada
- Employees
- STEM N/A
- EPRX N/A
- Industry
- STEM Computer Software: Prepackaged Software
- EPRX
- Sector
- STEM Technology
- EPRX
- Exchange
- STEM Nasdaq
- EPRX NYSE
- Market Cap
- STEM 100.2M
- EPRX 111.1M
- IPO Year
- STEM N/A
- EPRX N/A
- Fundamental
- Price
- STEM $0.36
- EPRX $3.30
- Analyst Decision
- STEM Hold
- EPRX Strong Buy
- Analyst Count
- STEM 9
- EPRX 1
- Target Price
- STEM $1.67
- EPRX $9.00
- AVG Volume (30 Days)
- STEM 5.7M
- EPRX 24.6K
- Earning Date
- STEM 10-30-2024
- EPRX 02-07-2025
- Dividend Yield
- STEM N/A
- EPRX N/A
- EPS Growth
- STEM N/A
- EPRX N/A
- EPS
- STEM N/A
- EPRX N/A
- Revenue
- STEM $256,183,000.00
- EPRX N/A
- Revenue This Year
- STEM N/A
- EPRX N/A
- Revenue Next Year
- STEM $143.79
- EPRX N/A
- P/E Ratio
- STEM N/A
- EPRX N/A
- Revenue Growth
- STEM N/A
- EPRX N/A
- 52 Week Low
- STEM $0.30
- EPRX $2.20
- 52 Week High
- STEM $4.28
- EPRX $4.08
- Technical
- Relative Strength Index (RSI)
- STEM 45.27
- EPRX N/A
- Support Level
- STEM $0.31
- EPRX N/A
- Resistance Level
- STEM $0.40
- EPRX N/A
- Average True Range (ATR)
- STEM 0.04
- EPRX 0.00
- MACD
- STEM 0.00
- EPRX 0.00
- Stochastic Oscillator
- STEM 35.83
- EPRX 0.00
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on innovative technology services that transform the way energy is distributed and consumed.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.